Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Dissecting the Mutational Landscape of Cutaneous Melanoma: An Omic Analysis Based on Patients from Greece.

Kontogianni G, Piroti G, Maglogiannis I, Chatziioannou A, Papadodima O.

Cancers (Basel). 2018 Mar 29;10(4). pii: E96. doi: 10.3390/cancers10040096.

2.

Dual IRE1 RNase functions dictate glioblastoma development.

Lhomond S, Avril T, Dejeans N, Voutetakis K, Doultsinos D, McMahon M, Pineau R, Obacz J, Papadodima O, Jouan F, Bourien H, Logotheti M, Jégou G, Pallares-Lupon N, Schmit K, Le Reste PJ, Etcheverry A, Mosser J, Barroso K, Vauléon E, Maurel M, Samali A, Patterson JB, Pluquet O, Hetz C, Quillien V, Chatziioannou A, Chevet E.

EMBO Mol Med. 2018 Mar;10(3). pii: e7929. doi: 10.15252/emmm.201707929.

3.

Integrative Bioinformatic Analysis of Transcriptomic Data Identifies Conserved Molecular Pathways Underlying Ionizing Radiation-Induced Bystander Effects (RIBE).

Yeles C, Vlachavas EI, Papadodima O, Pilalis E, Vorgias CE, Georgakilas AG, Chatziioannou A.

Cancers (Basel). 2017 Nov 25;9(12). pii: E160. doi: 10.3390/cancers9120160.

4.

Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.

Papadodima O, Moulos P, Koryllou A, Piroti G, Kolisis F, Chatziioannou A, Pletsa V.

PLoS One. 2016 Jul 28;11(7):e0160248. doi: 10.1371/journal.pone.0160248. eCollection 2016. No abstract available. Erratum in: PLoS One. 2018 Mar 8;13(3):e0194257.

5.

The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling.

Trachana SP, Pilalis E, Gavalas NG, Tzannis K, Papadodima O, Liontos M, Rodolakis A, Vlachos G, Thomakos N, Haidopoulos D, Lykka M, Koutsoukos K, Kostouros E, Terpos E, Chatziioannou A, Dimopoulos MA, Bamias A.

PLoS One. 2016 Jun 3;11(6):e0156403. doi: 10.1371/journal.pone.0156403. eCollection 2016.

6.

Novel pyrazolopyridine derivatives as potential angiogenesis inhibitors: Synthesis, biological evaluation and transcriptome-based mechanistic analysis.

Michailidou M, Giannouli V, Kotsikoris V, Papadodima O, Kontogianni G, Kostakis IK, Lougiakis N, Chatziioannou A, Kolisis FN, Marakos P, Pouli N, Loutrari H.

Eur J Med Chem. 2016 Oct 4;121:143-157. doi: 10.1016/j.ejmech.2016.05.035. Epub 2016 May 20.

PMID:
27240270
7.

The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway.

Pampalakis G, Obasuyi O, Papadodima O, Chatziioannou A, Zoumpourlis V, Sotiropoulou G.

Oncotarget. 2014 May 15;5(9):2390-403.

8.

HuR-regulated mRNAs associated with nuclear hnRNP A1-RNP complexes.

Papadodima O, Chatziioannou A, Patrinou-Georgoula M, Kolisis FN, Pletsa V, Guialis A.

Int J Mol Sci. 2013 Oct 11;14(10):20256-81. doi: 10.3390/ijms141020256.

9.

A comparative genomic study in schizophrenic and in bipolar disorder patients, based on microarray expression profiling meta-analysis.

Logotheti M, Papadodima O, Venizelos N, Chatziioannou A, Kolisis F.

ScientificWorldJournal. 2013;2013:685917. doi: 10.1155/2013/685917. Epub 2013 Mar 10.

10.

Application of an integrative computational framework in trancriptomic data of atherosclerotic mice suggests numerous molecular players.

Papadodima O, Sirsjö A, Kolisis FN, Chatziioannou A.

Adv Bioinformatics. 2012;2012:453513. doi: 10.1155/2012/453513. Epub 2012 Nov 6.

11.

A transcriptomic computational analysis of mastic oil-treated Lewis lung carcinomas reveals molecular mechanisms targeting tumor cell growth and survival.

Moulos P, Papadodima O, Chatziioannou A, Loutrari H, Roussos C, Kolisis FN.

BMC Med Genomics. 2009 Dec 15;2:68. doi: 10.1186/1755-8794-2-68.

12.

BM88/Cend1 is involved in histone deacetylase inhibition-mediated growth arrest and differentiation of neuroblastoma cells.

Politis PK, Akrivou S, Hurel C, Papadodima O, Matsas R.

FEBS Lett. 2008 Mar 5;582(5):741-8. doi: 10.1016/j.febslet.2008.01.052. Epub 2008 Feb 5.

13.

Characterization of the BM88 promoter and identification of an 88 bp fragment sufficient to drive neurone-specific expression.

Papadodima O, Sergaki M, Hurel C, Mamalaki A, Matsas R.

J Neurochem. 2005 Oct;95(1):146-59.

Supplemental Content

Loading ...
Support Center